Keep an eye on Closely (2)pentobarbital will decrease the level or effect of suvorexant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe. Robust CYP3A4 inducers could minimize suvorexant efficacy; if improved suvorexant dose demanded, never exceed twenty mg/working daypentobarbital will decrease the extent or influence